15,364 Shares in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Acquired by Northern Trust Corp

Northern Trust Corp purchased a new position in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) in the 4th quarter, Holdings Channel.com reports. The firm purchased 15,364 shares of the company’s stock, valued at approximately $93,000.

Several other large investors have also recently made changes to their positions in BIOX. Jump Financial LLC purchased a new stake in shares of Bioceres Crop Solutions during the fourth quarter worth approximately $72,000. Ping Capital Management Inc. boosted its stake in Bioceres Crop Solutions by 7.3% during the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock worth $268,000 after buying an additional 3,000 shares during the last quarter. Stifel Financial Corp boosted its stake in Bioceres Crop Solutions by 51.9% during the fourth quarter. Stifel Financial Corp now owns 61,958 shares of the company’s stock worth $377,000 after buying an additional 21,168 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in Bioceres Crop Solutions by 17.0% during the fourth quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company’s stock worth $640,000 after buying an additional 15,328 shares during the last quarter. Finally, Ballast Asset Management LP boosted its stake in Bioceres Crop Solutions by 23.5% during the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock worth $2,620,000 after buying an additional 82,187 shares during the last quarter. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Price Performance

Shares of NASDAQ BIOX opened at $5.00 on Wednesday. The stock’s 50-day moving average is $4.43 and its two-hundred day moving average is $5.39. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.33 and a quick ratio of 0.96. Bioceres Crop Solutions Corp. has a 1-year low of $3.51 and a 1-year high of $11.78. The company has a market cap of $313.56 million, a price-to-earnings ratio of 250.13 and a beta of 0.40.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings data on Wednesday, May 21st. The company reported ($0.02) EPS for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.08. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.58%. The business had revenue of $59.60 million for the quarter, compared to the consensus estimate of $61.80 million. Analysts forecast that Bioceres Crop Solutions Corp. will post -0.05 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on BIOX shares. Canaccord Genuity Group decreased their price target on Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Lake Street Capital decreased their price target on Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating on the stock in a research note on Friday, February 7th. Finally, Oppenheimer decreased their price target on Bioceres Crop Solutions from $8.00 to $7.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 22nd. Four investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $8.63.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.